PRQR
ProQR Therapeutics BV
NASDAQ: PRQR · HEALTHCARE · BIOTECHNOLOGY
$1.57
+1.95% today
Updated 2026-04-30
Market cap
$155.93M
P/E ratio
—
P/S ratio
9.54x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$1 – $3
Volume
0.6M
ProQR Therapeutics BV (PRQR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30000.00 | $160000.00 | $313000.00 | $9.41M | $2.28M | $-1.53M | $4.94M | $1.93M | $1.03M | $1.33M | $3.59M | $6.51M | $18.91M | $15.28M |
| Revenue growth (YoY) | — | +433.3% | +95.6% | +2905.4% | -75.7% | -167.0% | +423.2% | -60.9% | -46.8% | +29.7% | +169.2% | +81.2% | +190.2% | -19.2% |
| Cost of revenue | $583000.00 | $4.59M | $18.01M | $482849.00 | $1.28M | $1.00M | $983511.00 | $116.82M | $2.19M | — | $2.48M | $133524.00 | — | $2.60M |
| Gross profit | — | $116000.00 | $313000.00 | $8.92M | $1.00M | $-2.53M | $3.96M | $-114.89M | $1.03M | $1.33M | $3.59M | $6.51M | $18.91M | $12.68M |
| Gross margin | 0.0% | 72.5% | 100.0% | 94.9% | 43.8% | 165.5% | 80.1% | -5943.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 83.0% |
| R&D | $376000.00 | $2.57M | $10.27M | $23.40M | $31.92M | $31.15M | $29.51M | $46.49M | $38.13M | $42.22M | $50.87M | $25.15M | $36.36M | $40.72M |
| SG&A | — | $786000.00 | $6.51M | $6.84M | $9.48M | $10.84M | $12.54M | $12.89M | $13.69M | $17.37M | $18.65M | $16.24M | $13.66M | $15.06M |
| Operating income | — | $-3.24M | $-16.46M | $-27.00M | $-39.57M | $-40.50M | $-36.29M | $-57.45M | $-42.37M | $-57.21M | $-65.16M | $-31.86M | $-30.47M | $-42.15M |
| Operating margin | 0.0% | -2024.4% | -5259.1% | -287.1% | -1734.1% | 2648.7% | -734.5% | -2971.8% | -4117.4% | -4285.4% | -1813.0% | -489.1% | -161.2% | -275.9% |
| EBITDA | — | $-3.19M | $-49.70M | $-84.24M | $-120.55M | $-40.93M | $-35.29M | $-174.27M | $-48.44M | $-54.95M | $-56.46M | $-24.10M | $-24.12M | $-39.56M |
| EBITDA margin | 0.0% | -1994.4% | -15877.3% | -895.5% | -5282.5% | 2676.8% | -714.3% | -9015.4% | -4707.1% | -4116.0% | -1571.0% | -369.9% | -127.6% | -258.9% |
| EBIT | — | $-3.21M | $-49.82M | $-84.72M | $-121.83M | $-40.98M | $-36.27M | $-176.31M | $-50.79M | $-57.28M | $-58.98M | $-26.61M | $-26.88M | $-42.15M |
| Interest expense | $0.00 | $38000.00 | $265000.00 | $395000.00 | $538000.00 | $596000.00 | $810000.00 | $1.08M | $2.04M | $3.40M | $5.13M | $1.20M | $1.08M | $866400.00 |
| Income tax | — | $24000.00 | $-4.33M | $-6.17M | $-470000.00 | $2000.00 | $1000.00 | $132000.00 | $124000.00 | $117000.00 | $96000.00 | $-78000.00 | $-197000.00 | — |
| Effective tax rate | — | -0.7% | 26.3% | 22.9% | 1.2% | -0.0% | -0.0% | -0.2% | -0.3% | -0.2% | -0.1% | 0.3% | 0.7% | 0.0% |
| Net income | — | $-3.25M | $-12.13M | $-20.83M | $-39.10M | $-43.64M | $-36.89M | $-56.75M | $-46.56M | $-60.74M | $-64.42M | $-28.12M | $-27.76M | $-40.52M |
| Net income growth (YoY) | — | — | -272.8% | -71.8% | -87.7% | -11.6% | +15.5% | -53.8% | +17.9% | -30.4% | -6.1% | +56.4% | +1.3% | -45.9% |
| Profit margin | 0.0% | -2033.1% | -3874.4% | -221.5% | -1713.5% | 2854.0% | -746.7% | -2935.6% | -4525.3% | -4549.8% | -1792.5% | -431.7% | -146.9% | -265.2% |